Karuna Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Location
99 High Street, 26 Th Floor, Boston, MA

There are no Buy or Sell transactions made by insiders since 4/23/2024

Karuna Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Troy Ignelzi Chief Financial Officer $20M Aug 22, 2023
Charmaine Lykins Chief Commercial Officer $8.29M Nov 29, 2021
Heather Preston Director $3.02M Jun 24, 2021
Jeffrey M. Jonas Director $0 Mar 15, 2024
Christopher J. Coughlin Director $0 Mar 18, 2024
Steven M. Paul Director $0 Mar 18, 2024
Denice Torres Director $0 Mar 18, 2024
James Healy Director $0 Mar 18, 2024
William Meury President and CEO, Director $0 Mar 18, 2024
Laurie J. Olson Director $0 Mar 18, 2024
Stephen K. Brannan Chief Medical Officer $0 Mar 18, 2024
Jason Brown Chief Financial Officer $0 Mar 18, 2024
Atul Pande Director $0 Mar 18, 2024
David Wheadon Director $0 Mar 18, 2024
William P. Kane Jr Chief Commercial Officer $0 Mar 18, 2024
Andrew Craig Miller President of R&D $0 Mar 18, 2024

Recent Insider Transactions by Companies or Individuals for Karuna Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.